May 21, 2020 Epidemiology As Ontario opens up, the public-health-strategy-cart is ahead of the proverbial contact-tracing-and-testing-horse. Get your surfboard ready just in case.
May 14, 2020 Generic Drugs Will there be an increase in superbugs after SARS-CoV-2? Further evaluation is required to determine if there has been an increase in indiscriminate antibiotic use during the pandemic. We probably will not know the answer for some time.
May 13, 2020 Health Policy Health Canada’s approval of SARS-CoV-2 antibody test has its limitations but is a good first step to prepare for the easing of restrictions. Public health policy decisions will depend on its availability in significant quantity.
May 12, 2020 Epidemiology Unfortunately, we do not have the tests and contact tracing availability to fulfill the WHO “extreme vigilance” guidelines to safely return to work and reopen schools in Ontario and elsewhere in Canada.
May 11, 2020 Epidemiology Some provinces are acting prematurely to ease restrictions if we look at what has happened with cluster outbreaks in South Korea and in Germany. These are countries that are better prepared than us and it still happened.
May 8, 2020 Allergy/Immunology Interesting approach using monoclonal antibodies to treat Covid-19 infections. However clinical trials must follow to confirm in vitro findings.
May 5, 2020 Health Policy Strategy to relax the pandemic restrictions must be instituted nationwide and include accurate and copious testing and contact tracing in order to mitigate the second wave.
May 3, 2020 Health Policy Sunday House Call, #737, May 3, 2020: The “#Infodemic”. A conversation with @CaulfieldTim about the explosion of #COVID19 pandemic misinformation.
April 30, 2020 Clinical Research Remdesivir may help treat Covid-19 but the predictable media hype misrepresents the science. The data has not been published nor peer reviewed. There is a study in the Lancet that does not demonstrate efficacy hence the need for further investigation to determine if this truly is a treatment option.